Chickasaw Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Chickasaw Capital Management's NVS Position: Q4 2018 in Review
Chickasaw Capital Management sold out of Novartis (NVS) in Q4 2018, closing a stake of 8,928 shares — an estimated $689K sold.
Chickasaw Capital Management first reported a position in NVS in Q2 2013 and held it in 22 quarters. The position peaked at $960K in Q1 2014. 1,087 funds tracked by Wall St. Rank hold NVS as of Q4 2018.
- Chickasaw Capital Management reported no remaining Novartis position as of Q4 2018 after selling out during the quarter.
- Chickasaw Capital Management sold 8,928 Novartis shares in Q4 2018, an estimated $689K.
- Chickasaw Capital Management first reported a position in Novartis in Q2 2013 and held it in 22 quarters.
- Chickasaw Capital Management's Novartis position peaked at $960K in Q1 2014.
- 1,087 funds tracked by Wall St. Rank held Novartis as of Q4 2018.
Based on Chickasaw Capital Management's 13F filing for Q4 2018, filed 11 Jan 2019.